Running a Pharma Services RFP: Process, Timeline, Pitfalls

A step-by-step guide to running an RFP for pharma services vendors — hub services, market access, and beyond: phases, realistic timelines, scoring, and the mistakes that derail selections.

Published July 21, 2026

A well-run pharma services RFP takes roughly three to four months from requirements to signed contract: two to three weeks to define requirements and shortlist vendors, six to eight weeks for the competitive proposal and evaluation phase, and four or more weeks for negotiation and contracting. Industry procurement guidance consistently recommends inviting three to six qualified vendors, using a request for information (RFI) to narrow the field first, and scoring proposals against weighted criteria agreed on before the first response arrives. The most common failure is not a bad vendor — it is a vague RFP that produces incomparable proposals and forces the decision back onto relationships and price alone.

This guide covers the full cycle for services categories where pharma manufacturers most often run competitive selections: patient services hubs, market access and HEOR consultancies, copay program administrators, and adjacent commercial services.

Before you write anything: three prerequisites

1. A requirements document that reflects reality

An RFP is only as good as the requirements behind it. For a hub services RFP, that means documented patient volumes (or launch forecasts with scenarios), the service mix you actually need — benefit verification, prior authorization support, copay administration, nurse support, adherence programs — and your integration landscape: CRM, e-prescribing, specialty pharmacy data feeds. For a market access engagement, it means the specific deliverables (payer value proposition, pricing research, HEOR models, dossiers) and the internal team the vendor will work with. Vendors price uncertainty; every ambiguity in your requirements comes back as either padding or a change order.

2. Stakeholder alignment

Compliance, legal, procurement, IT, and the business owner should agree on the evaluation criteria and their weights before the RFP goes out. Pharma-specific guidance on vendor RFPs emphasizes engaging compliance and legal from the outset, not at contract stage — in a regulated category, a vendor that fails a compliance review after winning the evaluation wastes the entire process.

3. A shortlist built from an RFI, not a search engine

Procurement best practice is to use a short RFI to pre-qualify vendors on knockout criteria — therapeutic-area experience, required certifications, financial stability, conflict-of-interest checks — and only issue the full RFP to the three to six vendors that pass. Milliman’s guidance on pharmacy benefit RFPs makes the same point for a related category: proposals from three to six vendors give genuine comparison without drowning the evaluation team.

The process, phase by phase

Phase	Typical duration	Key outputs
Requirements and RFI	2–4 weeks	Requirements doc, weighted scorecard, shortlist of 3–6 vendors
RFP drafting and issuance	1–2 weeks	RFP document, Q&A and bidders’ call schedule, NDA execution
Vendor response window	3–4 weeks	Written proposals in a mandated response template
Evaluation and demos	2–3 weeks	Scored proposals, finalist demos or site visits, reference calls
Negotiation and contracting	4–8 weeks	Redlines, SLA schedule, pricing exhibits, signed MSA/SOW

A few structural details make a large difference:

Schedule a bidders’ conference two to three weeks after issuance. Vendors need time to read the RFP and formulate questions; answers should be shared with all bidders in writing.
Mandate a response template. Free-form proposals are effectively unscoreable. Require answers in your structure — service by service, with pricing in a standardized workbook — so evaluators compare like with like.
Score before you meet. Have each evaluator score written proposals independently against the weighted criteria before demos, then use demos and reference calls to challenge the scores rather than form them.
Keep two finalists through negotiation. Leverage evaporates the moment a single vendor knows it has won.

What to evaluate, by category

The scorecard differs by service line, but the categories below apply broadly.

Operational capability. For hubs: staffing model and ratios, turnaround-time SLAs for benefit verification and prior authorization, escalation paths, and business-continuity plans. Ask for performance data from comparable programs, and treat any vendor unwilling to commit to measurable SLAs as a signal.

Technology and integrations. Portals, e-services connectivity, data feeds to your CRM and data warehouse, and reporting cadence. Integration effort is chronically underestimated on both sides; require named integrations with named systems, not “flexible APIs.”

Compliance posture. HIPAA program, SOC 2 or equivalent audits, adverse-event and product-complaint handling procedures, and — for copay and financial assistance programs — controls relevant to fraud, waste, and abuse. Quality-system-oriented RFP guidance for regulated industries recommends auditing these claims during evaluation, not after award.

Pricing structure. Per-patient, per-transaction, FTE-based, and hybrid models each shift risk differently. Force every bidder into the same pricing workbook with the same volume scenarios, including a downside scenario. The cheapest bid at forecast volume is frequently the most expensive at actual volume.

Team and references. Who actually staffs your program versus who presented in the sales meeting. Reference calls with clients of comparable size and therapeutic area remain the single highest-value hour in the process.

Pitfalls that derail pharma services RFPs

Copy-paste RFPs. Reusing another program’s RFP produces requirements no one on your team can defend in Q&A, and vendors can tell.
Unrealistic response windows. Less than three weeks for a complex services RFP filters for vendors with the best proposal teams, not the best delivery teams.
Letting the incumbent write the requirements. Incumbents have a legitimate role in documenting current state, but requirements written around one vendor’s platform predetermine the outcome.
Ignoring vendor-landscape movement. Pharma services is consolidating rapidly — in May 2025, for example, hub providers Mercalis and PharmaCord completed their merger and rebranded as Valeris, a deal backed by Permira and Odyssey Investment Partners. A bidder can be acquired mid-RFP or mid-contract. Ask about ownership, and negotiate change-of-control protections into the contract.
Scoring the demo instead of the proposal. Demos reward polish. Weight written, contractually bindable commitments over presentation quality.
No transition plan. If you are displacing an incumbent, the RFP itself should require a transition plan with named milestones; switching costs are where weak selections become expensive.

Who you might be evaluating

The bidder pool depends on category. Hub services selections commonly include specialists and diversified providers such as AssistRx, CareMetx, ConnectiveRx, EVERSANA, and Valeris, among others. Market access and HEOR engagements draw from consultancies including Lumanity, Precision AQ, Trinity Life Sciences, and ZS Associates, alongside boutique firms such as The Dedham Group. These lists are illustrative, not exhaustive — the right pool is the one that matches your therapeutic area, program size, and integration requirements, which is exactly what the RFI stage exists to determine.

Practical recommendation

Budget twelve weeks minimum from RFP issuance to signature, and resist every pressure to compress the vendor response window — compression saves days and costs quarters. Before issuance, invest the two weeks it takes to produce a real requirements document and a weighted scorecard your compliance, IT, and business stakeholders have all signed. Then hold the process to its own rules: same information to all bidders, same template, same scenarios, independent scoring. An RFP run this way does more than select a vendor — it produces the SLA schedule, pricing exhibits, and performance baseline that make the vendor manageable for the life of the contract.